Washington [US], February 20 (ANI): Through a clinical study published in the European Heart Journal, scientists claim that around half of the patients studied have had their heart damaged subsequent to being hospitalised with severe COVID-19 and they showed elevated levels of a protein call
Massachusetts [US], February 14 (ANI): A new clinical study published in The New England Journal of Medicine today and simultaneously presented during the American Society of Clinical Oncology (ASCO) 2021 Genitourinary Cancers Symposium claims that a drug combination of Lenvatinib plus pemb
Washington [US], February 13 (ANI): Good news for all the coffee lovers out there! A clinical study drove by three renowned teams of researchers claimed that regular consumption of coffee can reduce the risk of heart failure.
London [UK], February 13 (ANI): A clinical study circulated by the British Medical Journal (BMJ) claims strong evidence that prompt preventive blood-thinning drugs may reduce the risk of death in COVID-19 patients.
North Carolina [US], February 12 (ANI): A clinical study by researchers of Duke University School of Medicine asserts that individuals who have a gene variant associated with an increased risk of developing Alzheimer's disease also tend to have changes in the fluid around their cerebrum and
Gothenburg [Sweden], February 7 (ANI): A clinical report drove by the University of Gothenburg features the danger for a serious type of retinopathy of rashness, which can cause visual impairment in very untimely infants, was halved when the babies were given a new supplement combining diffe
Kochi (Kerala) [India], December 16 (ANI/NewsVoir): Jackfruit365, a patented Green Jackfruit Flour brand, Founded by James Joseph, is now clinically proven to control blood sugar according to clinical study monitoring the effect of green jackfruit flour in Type 2 Diabetes Mellitus Patients.
Bengaluru (Karnataka) [India], December 12 (ANI/NewsVoir): Jagdale Healthcare, a subsidiary of Jagdale Industries, recently announced the results of a clinical study on their popular health drink Mulmina®. Suitable for consumption for all age groups, including children, Mulmina® is
New Delhi [India], August 19 (ANI): Indian pharmaceutical giant Serum Institute of India has initiated the phase 2, 3 clinical trials to evaluate the safety and immune response of coronavirus vaccine candidate on healthy Indian adults after the pharma company got approval from Drugs Controll
New Delhi [India], August 4 (ANI): While as many as 141 COVID-19 vaccine candidates are being studied by the scientists across the globe, India has three vaccine candidates which are in different phases of the clinical study, top ICMR scientist (Prof) Balram Bhargava informed on Tuesday.
New Delhi [India], July 15 (ANI): Indian pharmaceutical giant Zydus Cadila has initiated the phase 1, 2 clinical trial to evaluate the safety and immunogenicity of coronavirus vaccine candidate by intradermal (injection) route in 1,048 subjects after the pharma company got approval from D
Mumbai (Maharashtra)/New Delhi [India] Jan 25 (ANI/BusinessWire India): India Medtronic Private Limited, wholly-owned subsidiary of Medtronic plc, today announced the clinical data from the Onyx ONE Global Study, representing the first prospective, multi-center, randomized study evaluating c